Compare VMI & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VMI | DVA |
|---|---|---|
| Founded | 1946 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Misc Health and Biotechnology Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 10.1B |
| IPO Year | 1994 | 2002 |
| Metric | VMI | DVA |
|---|---|---|
| Price | $450.15 | $154.75 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $487.00 | $156.75 |
| AVG Volume (30 Days) | 145.5K | ★ 1.3M |
| Earning Date | 05-25-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.61% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 16.79 | 9.84 |
| Revenue | $3,169,556,000.00 | ★ $13,643,069,000.00 |
| Revenue This Year | $5.31 | $3.80 |
| Revenue Next Year | $4.70 | $3.04 |
| P/E Ratio | $26.63 | ★ $15.51 |
| Revenue Growth | ★ 14.52 | 6.46 |
| 52 Week Low | $250.07 | $101.00 |
| 52 Week High | $487.58 | $159.42 |
| Indicator | VMI | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 46.70 | 68.10 |
| Support Level | $438.00 | $135.14 |
| Resistance Level | $487.58 | N/A |
| Average True Range (ATR) | 15.22 | 4.54 |
| MACD | -3.23 | -0.45 |
| Stochastic Oscillator | 23.11 | 69.73 |
Valmont Industries Inc, along with its subsidiaries, operates as a manufacturer of products and services for infrastructure and agriculture markets. Its reportable segments are Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment, which includes the manufacturing and distribution of products and solutions to serve the infrastructure markets of utility, solar, lighting, transportation, and telecommunications, along with coatings services to protect metal products. The Agriculture segment provides irrigation equipment components, including aftermarket parts and tubular products, and technology solutions for precision agriculture. Geographically, it derives key revenue from the United States, followed by Australia, Brazil, and other regions.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.